Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

Global Companion Animal Vaccine Market Outlook

The global companion animal vaccine market is expected to grow at a CAGR of 6.2% during the period 2024-2032. The market is expected to be driven by the growing rate of adoption of companion animals, including rabbits, dogs, cats, etc. In recent years, some European countries have witnessed a significant increase in pet adoption. Pets or companion animals offer humans much needed interaction that offers social, medical, emotional and physical benefits. North America, Europe and Asia are expected to be key markets.

Global Companion Animal Vaccine Market Report Summary Description Value
Base Year USD Million 2023
Historical Period USD Million 2018-2023
Forecast Period USD Million 2024-2032
Market Size 2023 USD Million XX
Market Size 2032 USD Million XX
CAGR 2018-2023 Percentage XX%
CAGR 2024-2032 Percentage 6.2%
CAGR 2024-2032 - Market by Region Asia Pacific 7.2%
CAGR 2024-2032 - Market by Country India 8.2%
CAGR 2024-2032 - Market by Country China 6.8%
CAGR 2024-2032 - Market by Vaccines Live Attenuated Vaccines 7.1%
CAGR 2024-2032 - Market by Distribution Channel Veterinary Clinics 7.0%
Market Share by Country 2023 Germany 6.3%

Global Companion Animal Vaccine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Market Likely to be Driven by Advancements in Treatment Systems

Differing customer needs across regions characterize the animal health medicines, vaccines and diagnostics market space.  Factors include economic differences (standards of living in developing versus developed nations), cultural differences (including dietary preferences for separate animal proteins, pet ownership preferences and standards of pet care), epidemiological differences (for example, prevalence of particular bacterial and viral strains and aspects of  diseases), treatment differences (utilization of various types of vaccines and medicines, and rate of adoption of novel  technologies), environmental differences (seasonality, climate and the availability of arable land and fresh water), and regulatory differences.

Growth in the companion animal vaccines sector is propelled by economic development, associated increase in disposable income, and rise in pet ownership and expenditure on pet care. Advancements in animal health medicines, vaccines and diagnostics have led to longer lives of companion animals.

Vaccination has been an effective method to decrease disease burden in companion animals, pets and farm animals, and maintaining animal health and welfare. Vaccines play a crucial role in preventative health and disease control programmes in animals. Continual research, innovations and development of safe, effective and quality vaccines have enhanced protection for pets and farm animals. These developments are expected to stimulate the global companion animal vaccine market.

Effective Vaccines Available for Several Important Animal Diseases Likely to Boost Market Growth

Companion animals, pets and farm animals are susceptible to several diseases caused by viruses, bacteria, fungi and parasites. Today, vaccines come for many of these diseases, making it possible to prevent the diseases or minimizing the losses or long-term effects associated with the diseases. This assumes all the more importance when those diseases are considered that are complex, with limited or no available treatment alternatives.

Encouragingly, effective vaccines are nowadays available for several important animal diseases. The animal medicines sector continues to invest in research and development of veterinary vaccines to counter the various types of endemic and exotic diseases. A significant achievement in veterinary medicine in modern times includes the global eradication of a damaging livestock disease – Rinderpest – in 2011; vaccination played a key role therein. Modern veterinary vaccines are a result of several years of research and innovation, and meet multiple disease threats to pets, companion animals and farm animals. Vaccines stimulate immune responses in animals without causing the disease itself.

Main types of existing vaccines may be categorised as follows:

Modified-live (attenuated) – Such a vaccine carries an intact but weakened pathogen; the pathogen stimulates an immune response without causing clinical disease.

Inactivated (killed) – Such a vaccine carries a completely inactivated pathogen (the pathogen is no longer infectious), and generally contains an adjuvant (an added compound to help enhance protective immune response).

Recombinant – A vaccine produced with the help of genetic engineering technology, employing specific genetic material from a pathogen to make proteins to stimulate an immune response in animals after vaccination.

Toxoid – A vaccine based on inactivated toxins made by pathogens. These vaccines stimulate immunity and offer animals protection against these toxins. Through research and innovation, modern and sophisticated technologies like marker vaccines have been developed.

The development of different types of effective vaccines is expected to boost the global companion animal vaccine market.

Effective Vaccination can Prevent, Control or Alleviate Several Diseases in Companion Animals

Vaccines protect companion animals from a variety of diseases. Effective vaccination can prevent, control or alleviate several diseases in cats, including Feline Panleukopenia/Infectious Enteritis (Feline Panleukopenia or Parvovirus, FPV), Feline Rhinotracheitis (Feline Herpesvirus, FHV), Feline Calicivirus (FCV), Feline Leukaemia Virus (FeLV), Chlamydophila felis, and Feline Rabies, among others.

Significant canine diseases for which vaccines are available include Canine Distemper Virus (CDV), Canine Parvovirus (CPV), Canine Adenovirus (CAV), Canine Leptospira, Canine parainfluenza virus (CPi), Bordetella bronchiseptica, and Canine Rabies, among others.

Vaccines protect rabbits from two serious viral infectious diseases – myxomatosis and rabbit haemorrhagic disease.

Farm animals include species such as cattle, sheep, pigs, poultry, and farmed fish. This implies a wide range of potential disease threats, and vaccines are available to protect these farm animals.

Horses, in the form of companion animals, athletes and breeding stock, are exposed to multiple disease threats, according to their unique circumstances. Important equine vaccines include Equine Influenza, Tetanus, Equine Herpes Virus 1 and 4 (EHV-1 and EHV4), among others.

Global Companion Animal Vaccine Market Segmentation

Global Companion Animal Vaccine Market by Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By vaccines, the market is segmented into:

  • Live Attenuated Vaccines
  • Inactivated Vaccines 
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Subunit Vaccine
  • Conjugate Vaccine
  • DNA Vaccine
  • Others

By animal type, the market is divided into:

  • Feline
  • Canine
  • Bovine
  • Others

By disease, the market is classified into:

  • Rabies
  • Hepatitis
  • Leukemia
  • Others

By distribution channel, the market is segmented into:

  • Veterinary Clinics
  • Veterinary Hospitals 
  • Veterinary Research Institutes
  • Retail Pharmacies
  • Others

By region, the market is classified into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
CAGR 2024-2032 - Market by Country
India 8.2%
China 6.8%
Canada 5.8%
UK 5.7%
Italy 4.3%
USA XX%
Germany XX%
France XX%
Japan 4.3%
Australia XX%
Saudi Arabia XX%
Brazil XX%
Mexico XX%

Global Companion Animal Vaccine Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Global Companion Animal Vaccine Market

The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Boehringer Ingelheim
  • Intervet Inc. (Merck Animal Health)
  • Zoetis Services LLC
  • Bioveta, a.s.
  • Elanco Animal Health Incorporated
  • Zoetis Inc
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Vaccines
  • Animal Type
  • Disease
  • Distribution Channel
  • Region
Breakup by Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Subunit Vaccine
  • Conjugate Vaccine
  • DNA Vaccine
  • Others 
Breakup by Animal Type
  • Feline
  • Canine
  • Bovine
  • Others
Breakup by Disease
  • Rabies
  • Hepatitis
  • Leukemia
  • Others
Breakup by Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Boehringer Ingelheim
  • Intervet Inc. (Merck Animal Health)
  • Zoetis Services LLC
  • Bioveta, a.s.
  • Elanco Animal Health Incorporated
  • Zoetis Inc
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The global companion animal vaccine market is projected to grow at a CAGR of 6.2% between 2024 and 2032.

The major drivers of the market include the economic development, associated increase in disposable income, rise in pet ownership, expenditure on pet care, and advancements in animal health medicines, vaccines.

The growing rate of adoption of companion animals and advancements in treatment systems are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The different vaccines in the market are live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, subunit vaccine, conjugate vaccine, and DNA vaccine, among others.

Based on animal type, the market is divided into feline, canine, and bovine, among others.

The various diseases in the market are rabies, hepatitis, and leukemia, among others.

The several distribution channels are veterinary clinics, veterinary hospitals, veterinary research institutes, and retail pharmacies, among others.

The major players in the industry are Boehringer Ingelheim, Intervet Inc. (Merck Animal Health), Zoetis Services LLC, Bioveta, a.s., Elanco Animal Health Incorporated, and Zoetis Inc, among others.

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,999

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124